Navista Acquires Integrated Oncology Network in Corona del Mar

Integrated Oncology Network (ION), a company specializing in radiation oncology management and cancer center development, has agreed to be acquired by Navista, which is part of Cardinal Health, a major healthcare corporation. This acquisition, valued at $1.1 billion, was announced on September 20 and is pending regulatory approvals. Founded in 2011, ION has expanded significantly since its inception, particularly after being acquired by private equity firm Silver Oak in 2018. The company currently operates over 50 practice sites across 10 states, employing more than 100 healthcare providers. The acquisition aligns with Cardinal Health's strategic focus on enhancing its specialty services. Jason Hollar, the CEO of Cardinal Health, emphasized the importance of driving growth in specialty areas and highlighted the company's investments in expanding its offerings through both Navista and the recent acquisition of Specialty Networks. This move is indicative of a broader trend in the healthcare industry, where consolidation is becoming increasingly common as companies seek to enhance their service capabilities and market reach. Legal advisory for the transaction was provided by Ropes & Gray, ensuring that the acquisition process adheres to regulatory standards. The deal is expected to strengthen Navista's position in the oncology sector, allowing for improved management services and development of cancer centers, which are critical in addressing the growing demand for cancer care. As the healthcare landscape continues to evolve, this acquisition could have significant implications for patient care and the operational dynamics of oncology practices across the United States.